regul
gene
express
one
sever
role
propos
stressinduc
nucleotid
diadenosin
tetraphosph
ap
examin
directli
compar
rnaseq
analysi
chronic
myelogen
leukemia
cell
cell
ap
hydrolas
gene
disrupt
nuko
cell
caus
increas
intracellular
ap
differenti
express
gene
identifi
p
upregul
downregul
nuko
cell
foldchang
ingenu
pathway
analysi
ipa
use
assign
gene
known
canon
pathway
function
network
pathway
associ
interferon
respons
pattern
recognit
receptor
inflamm
score
highli
downregul
set
gene
function
associ
mhc
class
ii
antigen
promin
among
upregul
gene
otherwis
show
littl
organ
major
function
gene
set
tryptophan
catabol
also
strongli
downregul
numer
gene
known
involv
tumor
promot
system
role
epithelialmesenchym
transit
prolifer
invas
metastasi
convers
proapoptot
gene
upregul
major
upstream
factor
predict
ipa
gene
downregul
includ
major
factor
control
gene
upregul
identifi
potenti
mechan
gene
regul
mediat
ap
andor
disrupt
includ
bind
ap
corepressor
autocrin
activ
purinoceptor
ap
chromatin
remodel
effect
loss
transcript
stabil
inhibit
atpdepend
regulatori
factor
protein
kinas
ap
exist
evid
favor
last
probabl
mechan
regardless
result
suggest
protein
could
novel
cancer
chemotherapeut
target
inhibit
potenti
exert
strong
antitumor
effect
via
multipl
pathway
involv
metastasi
invas
immunosuppress
apoptosi
nudix
hydrolas
regul
level
wide
varieti
canon
modifi
nucleotid
nonnucleotid
phosphoryl
substrat
well
particip
essenti
process
mrna
decap
one
best
studi
mammalian
enzym
isol
mani
sourc
princip
substrat
believ
diadenosin
p
p
tetraphosph
ap
anim
cell
ap
synthes
aminoacyltrna
synthetas
dna
ligas
firefli
luciferas
acylcoa
synthetas
rang
enzym
abl
plant
fungi
bacteria
synthesi
usual
involv
transfer
amp
acylamp
enzymeamp
reaction
intermedi
atp
acceptor
also
degrad
number
enzym
addit
includ
fhit
aprataxin
nonspecif
phosphodiesteras
howev
believ
princip
respons
maintain
low
level
intracellular
ap
increas
ap
result
activ
synthesi
inhibit
degrad
implic
sever
intracellular
process
genotox
thermal
stress
lead
increas
ap
ap
implic
regul
dna
replic
dna
damag
promot
apoptosi
ap
may
also
rais
respons
extern
ligand
act
intracellular
second
messeng
also
act
extracellular
messeng
interact
number
receptor
ap
also
ligand
number
protein
includ
multiprotein
complex
contain
dna
protein
kinas
uracildna
glycosylas
protein
chaperon
tumor
suppressor
nucleotidas
ii
cb
domain
protein
case
signific
bind
clear
particular
interest
howev
possibl
ap
may
act
transcript
regul
suggest
increas
level
ap
induc
mast
cell
extern
factor
activ
express
subset
gene
control
mitf
transcript
factor
bind
displac
inhibitori
protein
factor
order
determin
whether
transcript
regul
ap
confin
rel
gene
widespread
analys
transcriptom
knockout
deriv
chronic
myeloid
leukaemia
cml
cell
line
intracellular
level
ap
increas
disrupt
gene
refer
hereaft
nuko
cell
show
profound
chang
gene
express
compar
parent
cell
line
total
significantli
differenti
express
gene
deg
identifi
ingenu
pathway
analysi
use
highlight
gene
network
metabol
signal
pathway
affect
reveal
downregul
interferon
inflammatori
innat
immun
respons
upregul
process
involv
mhc
class
ii
antigen
addit
mani
strongli
affect
gene
role
promot
cancer
metastasi
invas
suggest
may
offer
novel
pleiotrop
target
cancer
chemotherapi
modifi
eagl
medium
imem
sigma
supplement
vv
foetal
bovin
serum
sigma
mm
lglutamin
sigma
ml
penicillinstreptomycin
sigma
level
intracellular
ap
log
phase
nuko
cell
determin
previous
describ
use
sensit
luminometr
assay
slight
modif
use
suspens
cell
cell
harvest
suspens
centrifug
g
min
use
nucleotid
extract
ap
also
measur
growth
medium
supernat
cell
filter
millipor
filter
deprotein
tca
assay
adpribosyl
deriv
ap
adprap
separ
ionexchang
chromatographi
identifi
assay
previous
describ
cell
x
seed
cm
flask
contain
ml
growth
medium
chemic
agent
ad
state
cell
grown
h
cultur
centrifug
g
min
cell
resuspend
fresh
medium
count
use
haemocytomet
averag
count
normal
cell
count
untreat
cultur
three
independ
sampl
total
rna
prepar
nuko
cell
rna
extract
perform
use
qiagen
rneasi
mini
kit
qiashredd
quantiti
qualiti
determin
use
nanodrop
agil
bioanalyz
six
sampl
rna
dnasetr
use
ambion
turbo
kit
subsequ
purifi
use
ampur
xp
bead
dnasetr
total
rna
subject
rrna
deplet
use
ribozero
gold
humanmouserat
kit
purifi
ampur
xp
bead
success
deplet
assess
use
qubit
fluoromet
agil
bioanalyz
deplet
rna
use
rnaseq
librari
prepar
use
scriptseq
protocol
follow
cycl
amplif
librari
purifi
use
ampur
xp
bead
librari
quantifi
use
qubit
size
distribut
assess
use
agil
bioanalyz
final
librari
pool
equimolar
amount
use
qubit
bioanalyz
data
quantiti
qualiti
pool
assess
bioanalyz
qpcr
use
kapa
librari
quantif
kit
illumina
platform
roch
light
cycler
accord
manufactur
instruct
templat
dna
denatur
accord
protocol
describ
illumina
cbot
user
guid
load
concentr
pm
sequenc
carri
one
lane
illumina
hiseq
version
chemistri
gener
bp
pair
end
read
qualiti
control
maintain
phix
spikein
use
produc
secondstrand
librari
type
expect
map
strand
strand
read
align
refer
one
posit
discard
fkpm
valu
fragment
per
kilobas
transcript
per
million
read
map
calcul
differenti
gene
express
analysi
conduct
r
environ
use
edger
packag
count
data
normalis
across
librari
use
trim
mean
mvalu
tmm
method
edger
default
paramet
tagwis
dispers
paramet
estim
use
log
fc
log
fold
chang
estim
test
edger
use
likelihood
ratio
lr
test
p
valu
associ
log
fc
adjust
multipl
test
use
fals
discoveri
rate
fdr
approach
signific
deg
defin
fdradjust
p
valu
origin
rnaseq
data
produc
studi
submit
emblebi
arrayexpress
databas
access
number
rtpcr
analysi
select
gene
rna
extract
perform
use
qiagen
rneasi
mini
kit
qiashredd
cdna
synthes
use
biolin
tetro
cdna
synthesi
kit
accord
manufactur
instruct
cdna
quantit
pcr
use
maxima
sybr
green
master
mix
thermo
real
time
pcr
system
appli
biosystem
primer
obtain
sigma
list
tabl
method
use
determin
rel
transcript
level
use
housekeep
gapdh
gene
normal
data
gene
show
upor
downregul
fdradjust
p
valu
analyz
use
qiagen
ingenu
pathway
analysi
softwar
ipa
qiagen
redwood
citi
http
wwwingenuitycom
order
assign
differ
function
network
ipa
use
manual
curat
knowledg
base
contain
inform
sever
gene
protein
express
interact
annot
databas
intact
bind
mip
well
publish
literatur
also
use
ipa
identifi
function
relat
gene
correspond
specif
canon
pathway
signific
data
set
collect
curat
metabol
cellsign
cascad
diseaseassoci
pathway
fisher
exact
test
independ
use
calcul
probabl
associ
gene
dataset
canon
pathway
explain
chanc
alon
final
use
ipa
upstream
regul
analysi
identifi
factor
may
control
gene
pathway
highlight
network
analysi
provid
testabl
hypothes
gene
regul
ap
parent
line
use
studi
contain
gene
fusion
potenti
inactiv
mutat
lack
common
genet
aberr
found
myeloid
malign
express
major
annot
protein
wide
rang
signal
pathway
make
suitabl
cell
line
studi
complet
absenc
protein
nuko
disrupt
confirm
western
blot
fig
steadyst
concentr
intracellular
ap
unstress
mammalian
cell
typic
rang
cell
exact
amount
speciesand
cell
typedepend
log
phase
cell
level
n
cell
howev
nuko
deriv
increas
level
n
cell
provid
clearest
evid
yet
ap
import
substrat
vivo
enzym
play
essenti
role
maintain
low
background
level
ap
note
ap
content
cell
equat
roughli
intracellular
concentr
uniformli
distribut
level
nuko
cell
around
regard
whether
high
level
result
chang
cell
report
biolog
relev
previous
measur
ap
dna
repairdefect
cell
treat
mitomycin
c
concentr
high
report
mast
cell
chromatograph
analysi
ap
nuko
cell
show
present
form
adpribosyl
deriv
adprap
mainli
monoadprap
fig
previous
shown
adpribosyl
ap
chines
hamster
cell
mous
embryo
fibroblast
occur
respons
dna
damag
howev
appear
high
level
ap
subject
constitut
adpribosyl
ap
report
activ
transcript
subset
gene
control
transcript
factor
mitf
view
explor
phenotyp
knockout
cell
carri
compar
analysi
transcriptom
nuko
cell
rnaseq
identifi
deg
averag
million
pair
bp
pairedend
read
per
sampl
gener
align
refer
human
genom
align
result
summar
tabl
show
number
percentag
read
map
sampl
map
percentag
six
sampl
refer
gene
least
one
read
align
gene
read
align
six
sampl
differ
gene
express
profil
two
cell
type
illustr
princip
compon
analysi
pca
plot
gene
express
data
shown
fig
triplic
sampl
cell
type
group
well
away
indic
high
degre
differenti
gene
express
furthermor
heatmap
pearson
correl
coeffici
fig
indic
express
profil
three
sampl
cell
type
much
close
correl
sampl
differ
cell
type
show
effect
knockout
gene
express
much
stronger
influenc
technic
biolog
variat
sampl
heatmap
also
show
high
correl
r
among
sampl
cell
type
thu
conclud
differenti
gene
express
detect
statist
robust
read
map
tabl
total
deg
identifi
pvalu
fdradjust
upregul
downregul
foldchang
fig
tabl
plot
fig
show
fairli
symmetr
distribut
upand
downregul
gene
level
express
gene
upregul
downregul
foldchang
case
fpkm
one
wt
ko
dataset
strongli
downand
upregul
annot
gene
shown
tabl
respect
note
mani
gene
zero
read
count
either
wt
ko
dataset
necessit
addit
small
zerooffset
pseudocount
edger
softwar
order
calcul
log
fc
rnaseq
analysi
valid
perform
realtim
qrtpcr
select
gene
repres
variou
affect
pathway
fig
result
confirm
direct
regul
gene
studi
magnitud
chang
also
similar
major
gene
correl
coeffici
two
data
set
fig
inset
howev
gene
zero
valu
fpkm
one
sampl
rnaseq
analysi
use
pseudocount
method
edger
calcul
foldchang
led
significantli
differ
valu
eg
tnf
nevertheless
valu
calcul
edger
use
follow
discuss
avail
gene
still
good
rel
indic
chang
express
order
show
observ
differenti
gene
express
correl
sole
increas
ap
rather
relat
adprap
deriv
qrtpcr
analysi
also
perform
rna
extract
nuko
cell
grown
presenc
nm
inhibitor
prevent
synthesi
adprap
speci
result
similar
obtain
absenc
fig
show
gene
least
adprap
caus
differenti
express
function
adprap
still
unclear
order
place
gene
express
data
biolog
context
ingenu
pathway
analysi
ipa
softwar
use
assign
deg
known
canon
pathway
function
network
order
predict
biolog
function
transcript
chang
simplic
initi
analysi
includ
gene
upor
downregul
p
howev
present
result
pathway
network
gene
upor
downregul
also
consid
potenti
interest
biolog
justif
cutoff
valu
found
deg
map
larg
number
pathway
signific
enrich
score
log
pvalu
tabl
top
rank
within
upand
downregul
gene
set
signal
pathway
relat
immun
inflamm
pathway
associ
primarili
innat
immun
respons
activ
interferon
regulatori
factor
irf
pattern
recognit
receptor
prr
inflamm
specif
enrich
downregul
set
gene
function
associ
mhc
class
ii
antigen
specif
set
upregul
gene
tabl
predomin
pathway
dataset
may
reflect
myeloid
natur
cell
line
pathway
discuss
detail
interferon
respons
innat
immun
interferon
import
mediat
innat
immun
respons
provid
initi
vital
defenc
invad
pathogen
virus
bacteria
protozoa
follow
interact
pathogen
compon
prr
variou
cellular
compart
also
inhibit
cell
prolifer
modul
adapt
immun
respons
proor
antiinflammatori
depend
context
submiss
set
deg
fold
chang
interferom
databas
reveal
subset
least
deg
known
regul
type
ifn
system
roughli
half
overlap
set
show
known
regul
type
ii
ifn
also
show
type
iii
regul
potenti
uniqu
type
iii
tabl
tabl
jakstat
signal
pathway
central
interferon
respons
type
ii
interferon
signal
activ
homodim
bind
ga
interferon
gamma
activ
sequenc
promot
induc
gene
express
type
signal
involv
combin
heterodim
interferon
respons
factor
form
interferon
stimul
gene
factor
bind
isr
interferonstimul
respons
element
promot
downregul
respect
pathway
suppressor
upregul
though
individu
slight
combin
effect
chang
could
nevertheless
signific
increas
also
show
gener
suppress
gene
express
neg
feedback
via
gene
preserv
final
sever
statcontrol
gene
downregul
activ
ifn
respons
gene
eg
respect
canon
pathway
fig
highlight
role
three
helicas
prr
innat
immun
respons
activ
ifnb
follow
stimul
viral
doublestrand
rna
feedback
provid
express
prr
three
receptor
gene
downregul
respect
tabl
nuko
cell
addit
whose
product
restrict
entri
mani
virus
four
antivir
ifit
famili
member
bind
viral
compon
downregul
downregul
antivir
gene
includ
pkr
tabl
cytokin
signal
inflamm
signal
flag
ipa
top
downregul
pathway
tabl
reduc
express
import
proinflammatori
member
superfamili
exampl
mrna
receptor
accessori
protein
decreas
respect
respect
express
proinflammatori
also
reduc
express
tumor
necrosi
factor
tnf
activ
type
ifn
inflammatori
mediat
downregul
tabl
canon
pathway
lead
transcript
activ
ligand
shown
fig
complex
import
mediat
inflammatori
immun
respons
respond
prr
proinflammatori
cytokin
synerg
stat
signal
increas
induct
target
gene
result
coordin
bind
stat
ga
promot
compon
complex
relb
transactiv
downregul
mani
compon
signal
pathway
lead
activ
known
type
ifn
tnf
mutual
suppress
express
suggest
chang
crossregul
pathway
might
affect
balanc
potenti
destruct
protect
role
cytokin
pathogenesi
autoimmun
inflammatori
diseas
system
lupu
erythematosu
sle
rheumatoid
arthriti
ra
ipa
identifi
signal
ra
toprank
affect
canon
pathway
tabl
list
deg
associ
ra
sle
shown
tabl
although
modest
chang
express
cytokin
receptor
could
potenti
proinflammatori
eg
overal
pictur
one
upregul
canon
pathway
mhc
class
ii
antigen
cell
regard
immatur
precursor
profession
antigenpres
cell
macrophag
dendrit
cell
almost
top
upregul
canon
pathway
flag
ipa
involv
function
associ
adapt
immun
respons
includ
antigen
present
signal
allograft
reject
b
cell
develop
tabl
tabl
howev
emphas
larg
pathway
involv
one
promin
upregul
gene
set
induc
mhc
class
ii
antigen
mhcii
mhcii
molecul
mainli
concern
present
antigen
deriv
extracellular
pathogen
result
helper
cell
prime
product
antibodi
b
cell
almost
class
ii
subtyp
gene
show
signific
increas
express
show
larg
increas
eg
hladoa
thu
extent
canon
pathway
regard
upregul
whole
open
question
nevertheless
addit
mhcii
number
gene
involv
promot
aspect
adapt
immun
respons
upregul
nuko
cell
member
tnf
receptor
superfamili
express
activ
helper
cell
cell
engag
ligand
promot
clonal
expans
effector
memori
cell
respond
antigen
upregul
express
antigenpres
cell
interact
cell
surfac
ligand
crucial
effect
cell
activ
surviv
sever
studi
shown
downregul
blockad
improv
allograft
surviv
encod
chain
high
affin
ige
receptor
also
compon
sever
fc
receptor
tcell
receptor
may
explain
associ
ipa
sever
immun
function
interestingli
activ
mast
cell
aggreg
igeantigen
complex
report
promot
synthesi
ap
lysyltrna
synthetas
consequ
transcript
chang
upregul
might
therefor
provid
mechan
potenti
prolong
ap
synthesi
togeth
data
suggest
reinforc
element
adapt
immun
respons
elev
ap
far
cell
concern
may
indic
ap
promot
differenti
blastlik
phenotyp
matur
stage
appar
except
downregul
recombin
activ
gene
respect
rag
protein
catalyz
vdj
recombin
essenti
gener
matur
function
b
cell
gene
moder
express
cell
highli
express
blastphas
cmlderiv
cell
line
eg
howev
relev
immun
function
lymphocyt
express
normal
confin
context
may
downregul
high
ap
tryptophan
catabol
canon
pathway
analysi
also
show
number
metabol
pathway
includ
tryptophan
trp
catabol
consequ
de
novo
nad
biosynthesi
deriv
trp
strongli
associ
set
downregul
gene
fig
tabl
creatin
phosphat
biosynthesi
melatonin
degrad
also
trp
deriv
nad
phosphoryl
associ
set
upregul
gene
strong
downregul
major
pathway
trp
catabol
particularli
key
enzym
kynureninas
kynu
indoleamin
dopa
decarboxylas
trp
decarboxylas
ddc
particular
note
express
ratelimit
induc
myeloidlineag
cell
ifn
particularli
type
ii
tnf
act
synergist
increas
express
observ
downregul
pathway
nuko
cell
combin
moder
upregul
neg
effector
tyrobp
tumor
suppressor
tabl
would
expect
reduc
express
substanti
strong
evid
trp
catabol
express
dendrit
cell
myeloid
lineag
import
suppress
tcell
respons
promot
immun
toler
reduct
extracellular
trp
gener
metabolit
via
kynurenin
pathway
signal
function
tyrosinephosphoryl
contribut
immunosuppress
protect
autoimmun
diseas
allograft
reject
inhibit
prolifer
cell
nk
cell
promot
autophagi
anergi
strong
downregul
trp
catabol
caus
elev
ap
would
therefor
expect
promot
tcell
respons
suppress
toler
consist
upregul
adapt
immun
function
nuko
cell
predict
ipa
tabl
furthermor
overexpress
impact
inhibitor
stresssign
pathway
repress
translat
prolifer
respons
amino
acid
starvat
protect
tcell
trp
deplet
impact
upregul
nuko
cell
tabl
would
contribut
promot
tcell
respons
reproduc
cell
cancer
introduct
ap
cold
shock
cell
line
report
induc
cell
cycl
arrest
apoptosi
also
shown
level
express
posit
correl
lower
surviv
increas
lymph
node
metastas
breast
carcinoma
suggest
low
ap
might
promot
andor
high
ap
might
inhibit
cancer
progress
given
multifactori
natur
diseas
surpris
ipa
classifi
deg
chang
p
increas
decreas
affect
usual
mutat
associ
cancer
investig
whether
level
ap
might
correl
cancer
cell
prolifer
surviv
metastasi
filter
deg
set
exclud
fpkm
valu
wt
ko
sampl
focu
attent
abund
transcript
avoid
uncertainti
biolog
impact
deg
low
level
express
conduct
literatur
search
strongli
upregul
downregul
annot
proteincod
gene
satisfi
condit
tabl
exist
experiment
evid
suggest
reduc
express
top
downregul
gene
would
lead
signific
anticanc
effect
reduc
express
might
promot
effect
could
proor
anticanc
depend
cellular
context
top
upregul
gene
increas
express
restrict
cancer
progress
system
promot
one
could
possibl
either
tabl
thu
increas
intracellular
ap
seem
associ
overal
strong
anticanc
effect
detail
apprais
gene
follow
worth
note
wellcharacter
fhit
tumor
suppressor
protein
bind
ap
ap
express
cell
probabl
result
gene
delet
sever
gene
show
high
degre
differenti
express
associ
cell
system
epithelialmesenchym
transit
emt
loss
cellcel
adhes
initi
metastasisand
revers
process
mesenchymalepitheli
transit
met
stabil
integr
cancer
cell
tissu
encod
receptor
glial
cell
linederiv
neurotroph
factor
gdnf
classifi
edger
strongli
downregul
gene
dataset
prolifer
prostat
cancer
cell
resist
genotox
treatment
correl
directli
level
express
also
upregul
breast
carcinoma
releas
cell
promot
cancer
cell
migrat
invas
express
transcript
factor
mesenchym
prostat
cancer
poorli
differenti
breast
cancer
cell
induc
met
inhibit
metastat
potenti
propos
emtmet
balanc
regul
ratio
promot
met
promot
emt
express
upregul
nuko
cell
although
express
decreas
slightli
respect
secret
glycoprotein
recent
identifi
novel
induc
emt
hepatocellular
carcinoma
promot
cell
migrat
invas
angiogenesi
also
upregul
oral
squamou
cell
carcinoma
downregul
nuko
cell
mrna
bind
protein
promot
emt
knockdown
reduc
cell
migrat
variou
mesenchymallik
tumor
cell
recent
character
key
gene
cervic
cancer
invas
metastasi
nuko
cell
transmembran
protein
overexpress
mani
cancer
tumor
vascular
endothelium
level
correl
poor
prognosi
glioblastoma
downregul
endogen
mirna
prostat
cancer
cell
inhibit
migrat
invas
overexpress
pituitari
gonadotrop
cell
promot
prolifer
migrat
invas
express
significantli
decreas
breast
carcinoma
cell
growtharrest
sirna
knockdown
migrat
invas
regulatori
proprotein
convertas
express
reduc
nuko
cell
guanin
nucleotid
exchang
factor
frequent
mutat
cancer
promot
migrat
invas
variou
neoplasia
high
express
famili
member
found
correl
colorect
tumor
progress
invas
poor
respons
neoadjuv
concurr
chemoradiotherapi
downregul
nuko
cell
downregul
transcript
factor
promot
emt
phenotyp
breast
cancer
cell
caus
prolifer
invas
vivo
vitro
overexpress
inhibit
phenotyp
similar
result
found
cancer
upregul
nuko
cell
overexpress
neg
regul
wnt
signal
metastat
osteosarcoma
breast
carcinoma
significantli
reduc
tumor
growth
metastasi
vivo
decreas
cell
prolifer
migrat
invas
vitro
downregul
opposit
effect
upregul
leukemia
inhibitori
factor
receptor
lifr
shown
act
suppressor
metastasi
hepatocellular
carcinoma
increas
lifr
activ
also
correl
reduct
pool
breast
cancer
stem
cell
upregul
sever
promin
deg
known
affect
growth
apoptosi
system
wilm
tumor
transcript
regul
exhibit
oncogen
tumor
suppressor
activ
depend
associ
specif
coregul
exampl
corepressor
interact
complex
phb
favor
growth
arrest
induct
apoptosi
prolifer
gene
well
express
cell
exhibit
upregul
nuko
cell
upregul
associ
melanoma
prostat
cancer
overexpress
associ
ewe
sarcoma
fibromatosi
respect
nuko
cell
homeobox
transcript
factor
prostat
tumor
suppressor
express
increas
nuko
cell
overexpress
coil
coil
domain
protein
decreas
prolifer
tumorigen
pancreat
ductal
adenocarcinoma
cell
allel
loss
found
half
tumor
examin
also
identifi
possibl
tumor
suppressor
colorect
cancer
upregul
nuko
cell
even
gene
modest
chang
express
could
profound
anticanc
effect
exampl
interferon
regulatori
factor
import
regul
immun
system
develop
innat
immun
respons
also
play
essenti
role
mani
lymphoid
malign
knockdown
express
lethal
multipl
myeloma
cell
downregul
nuko
cell
mix
result
report
deg
context
exampl
high
express
cysteinerich
secretori
protein
nuko
cell
found
certain
subtyp
prostat
cancer
downregul
associ
oral
squamou
cell
carcinoma
similar
pattern
found
jchain
compon
iga
igm
upregul
prostat
downregul
colorect
cancer
chemokin
anoth
factor
tumorpromot
antitumor
effect
latter
larg
immunogen
action
overexpress
type
cancer
promot
tumor
cell
growth
metastasi
nuko
cell
mix
result
also
report
ig
superfamili
protein
transmembran
coreceptor
proand
anticanc
role
suggest
differ
situat
nuko
cell
respect
chang
express
small
number
gene
nuko
cell
could
potenti
promot
cancer
exampl
reduc
express
earli
bcell
factor
found
hodgkin
lymphoma
appear
contribut
loss
bcell
phenotyp
consequ
malign
also
evid
tumor
suppressor
role
mous
leukemia
downregul
express
tnf
famili
member
normal
restrict
activ
bcell
activ
wide
varieti
tumor
promot
tumor
cell
expans
surviv
upregul
final
type
ii
transglutaminas
upregul
nuko
cell
may
import
role
maintain
surviv
invas
metastat
behavior
varieti
tumor
cancer
stem
cell
phosphatas
may
target
tumor
suppressor
set
promin
deg
express
respond
way
increas
ap
carcinoma
overwhelm
net
effect
could
strong
suppress
tumor
growth
particularli
metastasi
furthermor
indic
previous
sever
enzym
trp
catabol
strongli
downregul
nuko
cell
increas
express
characterist
mani
cancer
cell
assist
avoid
clearanc
immun
system
level
express
often
correl
poor
prognosi
inhibitor
consid
novel
immunotherapeut
adjuv
convent
anticanc
drug
taken
togeth
seem
suffici
evid
support
novel
chemotherapeut
target
could
conceiv
exert
anticanc
effect
via
multipl
pathway
involv
apoptosi
metastasi
invas
immunosuppress
one
addit
benefit
target
could
downregul
methylguaninedna
methyltransferas
mgmt
mgmt
protein
dealkyl
toxic
mutagen
alkylguanin
lesion
dna
expos
alkyl
agent
reduc
express
nuko
cell
render
much
sensit
growth
inhibit
methylmethan
sulfon
mm
nmethylnnitronnitrosoguanidin
mnng
nmethylnitrosourea
mnu
fig
downregul
high
ap
would
theori
promot
carcinogen
effect
environment
alkyl
agent
would
also
render
cancer
cell
sensit
alkyl
therapi
temozolomid
common
treatment
glioblastoma
astrocytoma
mgmt
statu
import
determin
success
therapi
sensit
methyl
agent
also
provid
good
phenotyp
confirm
transcriptom
data
ipa
predict
upstream
regulatori
factor
ipa
predict
key
upstream
regul
deg
suggest
numer
factor
control
larg
set
downregul
gene
fewer
factor
control
small
group
upregul
gene
top
signific
potenti
regul
propos
contribut
gene
downregul
tabl
although
total
number
gene
upand
downregul
similar
interrelationship
toprank
transcript
factor
implic
gene
downregul
major
identifi
target
shown
fig
function
sever
alreadi
describ
addit
neg
regul
type
type
ii
ifn
signal
transcript
factor
import
respond
prr
activ
fig
cooper
transcript
gene
control
transcript
multipl
gene
mani
describ
promot
hallmark
cancer
prolifer
independ
growth
signal
avoid
apoptosi
immun
destruct
invas
metastasi
angiogenesi
overexpress
mani
tumor
make
target
chemotherapi
control
upregul
gene
appear
less
integr
differ
factor
potenti
regul
small
subset
gene
tabl
furthermor
top
five
list
regul
myoc
tabl
littl
express
method
data
present
mean
sem
result
obtain
three
independ
experi
error
bar
shown
error
smaller
symbol
statist
signific
assess
student
twotail
ttest
p
p
p
versu
wt
control
myoc
detect
signific
hard
determin
case
mhcii
gene
subunit
cohesin
protein
complex
identifi
possibl
regul
cohesin
cooper
mhcii
specif
transcript
factor
ciita
activ
mhcii
express
atpbind
domain
whether
cohesin
bind
mhcii
transcript
insul
could
promot
ap
unknown
ubiquitin
ligas
slim
predict
ipa
upregul
downregul
differ
set
gene
tabl
predict
appear
base
larg
result
one
previou
investig
gene
express
prostat
carcinoma
cell
direct
express
chang
half
gene
studi
differ
given
zscore
predict
signific
threshold
z
reliabl
predict
perhap
question
nevertheless
suppress
known
alter
stabil
sever
transcript
factor
famili
implic
downregul
respons
nuko
cell
includ
irf
stat
jun
also
promot
revers
emt
phenotyp
although
level
express
cell
significantli
affect
knockout
tabl
activ
may
alter
secondari
effect
chang
eg
protein
kinas
overal
though
clear
upstream
pattern
regul
set
upregul
gene
ipa
may
identifi
potenti
upstream
regulatori
factor
observ
chang
gene
express
question
still
remain
elev
level
ap
impact
factor
promot
chang
number
possibl
consid
studi
initi
suggest
razin
cowork
direct
activ
mitf
transcript
complex
mastrel
cell
occur
ap
amedi
displac
corepressor
exampl
mast
cell
proteas
ckit
kit
granzym
b
gzmb
tryptophan
hydroxylas
upregul
rbl
cell
either
direct
introduct
ap
activ
ige
antigen
increas
ap
sirna
knockdown
howev
ipa
identifi
mitf
potenti
regul
studi
furthermor
kit
unaffect
tabl
data
retriev
gzmb
gene
shp
tert
also
shown
upregul
ap
rbl
cell
studi
express
unchang
knockout
lowlevel
express
tert
thb
tabl
data
obtain
elev
ap
also
found
activ
mitfdepend
transcript
myosin
light
chain
cardiomyocyt
gene
express
cell
list
gene
shown
upregul
mitf
melanoma
upand
downregul
nuko
cell
would
suggest
ap
amedi
mitf
activ
promin
data
gene
repress
interact
mitf
complex
includ
cyclin
met
myc
tgfb
myc
slightli
upregul
downregul
loss
also
report
reduc
express
predict
slight
reduct
express
observ
nuko
cell
thu
clear
evid
support
relief
repress
transcript
factor
caus
ap
amedi
differenti
gene
express
cell
purinoceptor
ap
amedi
transcript
chang
could
also
involv
extern
ap
growth
medium
exocytosi
damag
necrot
cell
ap
could
act
cellsurfac
purinoceptor
modul
known
signal
pathway
lead
chang
gene
express
known
receptor
subtyp
except
found
express
cell
show
slight
signific
upregul
nuko
cell
tabl
sever
known
activ
ap
howev
measur
ap
cellfre
growth
medium
show
actual
less
medium
taken
nuko
cell
cell
n
cell
cell
n
possibl
due
upregul
cell
surfac
phosphodiesteras
known
hydrolyz
extracellular
diadenosin
polyphosph
thu
increas
autocrin
signal
effect
ap
seem
unlik
chromatin
remodel
known
intim
involv
chromatin
de
condens
epigenet
mark
adpribosyl
histon
chromatin
remodel
enzym
via
interact
numer
transcript
factor
profound
effect
gene
express
ap
effect
compet
histon
adpribos
acceptor
result
synthesi
adprap
speci
elev
level
ap
could
conceiv
regul
interfer
process
lead
chang
gene
regul
howev
lack
effect
express
select
gene
set
studi
qrtpcr
inhibit
would
argu
major
role
parp
nevertheless
express
larg
number
histon
gene
variant
affect
disrupt
major
downregul
chang
express
sever
lysinespecif
demethylas
kdm
histon
deactylas
hdac
dna
methyltransferas
dnmt
sever
also
adpribosyl
target
also
evid
tabl
henc
ap
amedi
chromatin
remodel
unknown
mechan
could
still
consid
potenti
sourc
differenti
gene
express
protein
kinas
atpdepend
factor
virtu
structur
similar
atp
ap
might
regul
transcript
inhibit
protein
kinas
human
genom
ap
shown
inhibit
vsrc
casein
kinas
ii
protein
kinas
c
mani
protein
kinas
might
particularli
sensit
ap
known
regul
transcript
factor
activ
directli
indirectli
sever
exampl
potenti
target
featur
fig
absenc
evid
strongli
favor
altern
possibl
protein
kinas
atpdepend
regulatori
factor
phosphoinositid
kinas
chaperon
abc
transport
must
regard
like
target
ap
requir
futur
investig
transcript
stabil
altern
mechan
wherebi
increas
ap
could
major
effect
transcriptom
inhibit
rna
bind
nudix
protein
kda
compon
cleavag
factor
im
complex
involv
premrna
end
process
ap
bind
site
rna
k
might
expect
affect
end
process
halfliv
certain
mrna
knockdown
glioblastoma
cell
result
shorten
utr
transcript
increas
cell
prolifer
transcript
steadyst
level
significantli
increas
decreas
howev
comparison
transcript
affect
knockdown
glioblastoma
cell
upand
downregul
nuko
cell
reveal
overlap
downregul
gene
overlap
top
upregul
gene
therefor
despit
differ
cell
line
seem
unlik
import
target
increas
ap
nuko
cell
altern
substrat
effect
disrupt
vitro
substrat
whose
level
might
affect
loss
includ
ap
ap
homodinucleosid
polyphosph
four
phosphoryl
group
eg
diguanosin
tetraphosph
gp
g
inorgan
polyphosph
phosphoribosyl
pyrophosph
evid
suggest
signific
substrat
vivo
ap
ap
appear
confin
secretori
granul
certain
special
cell
specif
mechan
known
synthesi
gp
g
homodinucleosid
polyphosph
mammalian
cell
heterodinucleosid
polyphosph
ap
g
ap
u
also
synthes
aminoacyltrna
synthetas
present
would
detect
luminometr
assay
includ
part
ap
pool
uniqu
function
ascrib
molecul
usual
consid
head
ap
transcript
stabil
could
also
affect
involv
mrna
decap
far
two
relat
nudix
famili
protein
shown
particip
mrna
decap
vivo
howev
six
nudix
protein
includ
vari
degre
decap
activ
vitro
monomethyl
unmethyl
cap
rna
although
current
evid
support
decap
vivo
possibl
discount
addit
virtu
structur
similar
cap
elev
ap
could
conceiv
inhibit
decap
case
would
like
lead
prolong
halfliv
mrna
subset
might
therefor
contribut
upregul
certain
gene
final
loss
could
consequ
loss
interact
bind
partner
may
signific
nuclear
locat
document
bind
replic
helicas
compon
may
way
relat
inhibit
replic
initi
ap
clear
loss
interact
would
profound
effect
transcript
observ
nuko
cell
also
report
bind
unligand
estrogen
receptor
beta
cytosol
interest
given
report
repress
express
estradiol
howev
signific
express
detect
cell
tabl
seem
unlik
effect
disrupt
involv
gene
express
thu
asid
theoret
effect
loss
mrna
decap
seem
reason
conclud
transcript
effect
report
caus
increas
level
major
substrat
ap
attempt
answer
question
directli
express
escherichia
coli
apah
gene
nuko
cell
apah
encod
symmetricallycleav
ap
hydrolas
structur
unrel
hope
reduc
ap
normal
level
background
howev
apah
express
prove
toxic
cell
possibl
apah
may
also
protein
phosphatas
activ
despit
known
sinc
ap
never
command
attent
bestow
lowmolecularweight
regul
cyclic
nucleotid
inositol
phosphat
two
compet
school
thought
arisen
one
suggest
ap
physiolog
import
regul
whose
level
fine
tune
ap
hydrolas
unavoid
nonfunct
byproduct
sever
enzym
activ
exist
simpli
elimin
lest
caus
molecular
mayhem
interf
essenti
adenin
nucleotidedepend
metabol
regulatori
pathway
data
present
clearli
demonstr
increas
intracellular
ap
disrupt
singl
gene
lead
signific
chang
transcript
program
observ
chang
gene
express
may
inde
adventiti
due
unregul
sustain
high
level
ap
specif
downregul
gene
set
involv
interferon
inflammatori
innat
immun
respons
cancer
promot
support
view
ap
inde
biolog
relev
regul
assum
ap
one
intracellular
target
like
differ
gene
set
respond
differ
level
ap
result
regul
activ
translat
transcript
vivo
respons
differ
factor
effect
observ
nuko
cell
necessarili
occur
time
identif
target
gene
network
control
prioriti
futur
work
take
posit
view
ap
bona
fide
regul
conclus
drawn
princip
intracellular
role
rapid
suppress
interferon
respons
activ
initi
signal
transduct
pathway
essenti
part
overal
immun
respons
pathogen
avoid
potenti
toxic
mani
antivir
proapoptot
antiprolif
protein
induc
therefor
nuko
phenotyp
may
reflect
activ
feedback
mechan
altern
compon
infect
pathogen
protein
ppp
rna
may
activ
caus
increas
intracellular
ap
inhibit
order
downregul
immun
respons
polioviru
infect
known
caus
slight
increas
ap
sar
coronaviru
protein
physic
interact
although
effect
level
ap
known
recent
shown
viralinduc
mediat
interferon
respons
cyclic
gamp
transfer
cell
cell
insid
newlyform
virion
specul
protect
hostregul
mechan
rapidli
establish
antivir
state
newli
infect
cell
equal
interest
specul
virus
may
also
packag
ap
new
virion
counteract
regard
bacteri
pathogen
two
type
bacteri
ap
hydrolas
asymmetricallycleav
homologu
rpph
also
known
ygdp
iala
unrel
symmetricallycleav
apah
classifi
invas
protein
requir
optim
surviv
bacteria
cellular
invas
may
help
prevent
high
host
cell
ap
induc
infectionassoci
stress
inhibit
essenti
bacteri
function
downregul
tryptophan
catabol
ap
offer
possibl
explan
aminoacyltrna
synthetas
abl
gener
diadenosin
oligophosph
mammalian
tryptophanyltrna
synthetas
wr
one
unabl
synthesis
ap
make
ap
wr
express
constitut
cell
strongli
induc
mani
nonlymphoid
cell
eg
monocyt
type
ii
interferon
lead
mark
increas
ap
ap
propos
induct
protect
nonlymphoid
cell
trp
deplet
effect
express
ensur
suffici
trp
divert
protein
synthesi
surviv
enhanc
wr
express
cell
patient
sever
autoimmun
disord
also
believ
protect
trp
deplet
increas
level
wr
also
gener
signific
amount
ap
would
compromis
intend
immunosuppress
downregul
trp
catabol
henc
wr
may
evolv
uniqu
inabl
make
ap
also
seem
confirm
physiolog
relev
ap
import
signal
molecul
regardless
mechan
ap
exert
effect
whether
physiolog
relev
practic
signific
inhibit
evid
result
expand
upon
earlier
demonstr
promot
prolifer
breast
carcinoma
cell
statu
could
use
prognost
marker
potenti
pleiotrop
therapeut
target
cancer
simultan
affect
metastasi
invas
apoptosi
immunosuppress
inflamm
certainli
warrant
investig
valid
differ
cancer
cell
anim
model
current
known
specif
small
molecul
inhibitor
howev
molecul
describ
relat
nudix
hydrolas
suggest
specif
inhibit
may
feasibl
could
also
target
biotherapeut
extent
chang
express
gene
pathway
brought
disrupt
might
milit
valu
target
determin
investig
support
inform
tabl
primer
use
qrtpcr
verif
rnaseq
data
docx
tabl
raw
data
read
map
human
refer
genom
data
includ
ensembl
gene
id
chromosom
map
data
log
count
per
million
map
read
cpm
log
fold
chang
four
contrast
pvalu
fdradjust
pvalu
raw
count
individu
sampl
mean
fpkm
valu
tabl
contain
gene
zero
read
count
librari
xlsx
tabl
list
subset
gene
show
differenti
express
cell
foldchang
p
data
includ
ensembl
gene
id
log
cpm
mean
fkpm
valu
triplic
ko
wt
sampl
log
fold
chang
fold
chang
upregul
red
downregul
green
fdradjust
pvalu
approv
gene
name
list
includ
unannot
gene
pseudogen
nonprotein
code
gene
xlsx
tabl
map
deg
canon
pathway
data
includ
observ
overal
direct
regul
log
pvalu
zscore
key
molecul
pathway
xlsx
tabl
deg
studi
previous
shown
regul
type
b
type
ii
andor
c
type
iii
interferon
accord
interferom
databas
data
includ
ensembl
id
gene
id
descript
fold
red
green
regul
studi
gene
potenti
show
specif
regul
type
iii
ifn
highlight
yellow
xlsx
tabl
gene
identifi
ipa
associ
rheumatoid
arthriti
system
lupu
erythematosu
tabl
upstream
regul
predict
ipa
data
includ
predict
upstream
regul
direct
regul
associ
type
molecul
activ
state
predict
direct
biolog
function
activ
zscore
significantli
predict
pvalu
molecul
document
evid
regul
top
transcript
factor
examin
